Highbridge Capital Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-111,475
Closed -$4.29M 380
2018
Q3
$4.29M Buy
+111,475
New +$3.89M 0.1% 225
2018
Q1
Sell
-655,213
Closed -$17.8M 1205
2017
Q4
$16.2M Buy
+655,213
New +$18.1M 0.29% 74
2017
Q3
Sell
-28,761
Closed -$797K 1541
2017
Q2
$797K Sell
28,761
-32,504
-53% -$863K 0.01% 619
2017
Q1
$1.52M Buy
+61,265
New +$1.49M 0.02% 500
2016
Q4
Sell
-56,336
Closed -$1.34M 1269
2016
Q3
$1.34M Buy
+56,336
New +$1.34M 0.02% 493
2015
Q2
Sell
-1,722,426
Closed -$30.6M 1404
2015
Q1
$30.6M Buy
1,722,426
+1,708,489
+12,259% +$27M 0.42% 59
2014
Q4
$185K Sell
13,937
-439,266
-97% -$5.62M ﹤0.01% 1074
2014
Q3
$5.35M Buy
+453,203
New +$5.71M 0.07% 293
2014
Q2
Sell
-573,046
Closed -$7.75M 1065
2014
Q1
$7.75M Buy
573,046
+520,887
+999% +$6.84M 0.1% 220
2013
Q4
$627K Buy
52,159
+16,308
+45% +$193K 0.01% 624
2013
Q3
$421K Buy
+35,851
New +$388K ﹤0.01% 932

Other funds holding BSX

Highbridge Capital Management's BSX Position: Q4 2018 in Review

Highbridge Capital Management sold out of Boston Scientific (BSX) in Q4 2018, closing a stake of 111,475 shares — an estimated $4.29M sold.

Highbridge Capital Management first reported a position in BSX in Q3 2013 and held it in 11 quarters. The position peaked at $30.6M in Q1 2015. 731 funds tracked by Wall St. Rank hold BSX as of Q4 2018.

  • Highbridge Capital Management reported no remaining Boston Scientific position as of Q4 2018 after selling out during the quarter.
  • Highbridge Capital Management sold 111,475 Boston Scientific shares in Q4 2018, an estimated $4.29M.
  • Highbridge Capital Management first reported a position in Boston Scientific in Q3 2013 and held it in 11 quarters.
  • Highbridge Capital Management's Boston Scientific position peaked at $30.6M in Q1 2015.
  • 731 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2018.

Based on Highbridge Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.